A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Khattak, Aamer A ^a   Venkatesan, Meera ^b,c   Jacob, Christopher G ^b   Artimovich, Elena M ^b   Nadeem, Muhammad F ^d,e   Nighat, Farida ^f   Hombhanje, Francis ^g   Mita, Toshihiro ^h   Malik, Salman A ^a   Plowe, Christopher V ^b,c  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d KING EDWARD MEDICAL UNIVERSITY   (Pakistan)

^e UNIVERSITY OF GUJRAT   (Pakistan)

^f Islamic International Medical College   (Pakistan)

^g Divine Word University   (Papua New Guinea)

^h JUNTENDO UNIVERSITY   (Japan)

Author keywords

ACT; Chloroquine; Drug resistance; Malaria; Pakistan; pfcrt; pfdhfr; pfdhps; pfmdr1; Plasmodium falciparum; Sulphadoxine pyrimethamine

Indexed keywords

ARTEMISININ; ARTESUNATE; BENFLUMETOL; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; MEFLOQUINE; MICROSATELLITE DNA; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; SULFADOXINE;

ADOLESCENT; ADULT; ANTIMALARIAL DRUG RESISTANCE; BLOOD SAMPLING; CODON; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MULTIDRUG RESISTANCE; PAKISTAN; PAPUA NEW GUINEA; PARASITE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PREVALENCE; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SELECTIVE SWEEP;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DNA, PROTOZOAN; DRUG RESISTANCE; FEMALE; GENE DOSAGE; GENOTYPE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PAKISTAN; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84883088568     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-300     Document Type: Review

References (53)

1. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan. Ghanchi NK, Ursing J, Beg MA, Veiga MI, Jafri S, Martensson A, Malar J 2011 10 18 10.1186/1475-2875-10-18 21272384
2. Chloroquine resistance in Pakistan and the upsurge of falciparum malaria in Pakistani and Afghan refugee populations. Shah I, Rowland M, Mehmood P, Mujahid C, Razique F, Hewitt S, Durrani N, Ann Trop Med Parasitol 1997 91 591 602 10.1080/00034989760680 9425361 (Pubitemid 27434593)
3. Falciparum malaria and climate change in the northwest frontier province of Pakistan. Bouma MJ, Dye C, van der Kaay HJ, Am J Trop Med Hyg 1996 55 131 137 8780449 (Pubitemid 26299195)
4. Resistance of Plasmodium falciparum malaria to chloroquine is widespread in eastern Afghanistan. Rab MA, Freeman TW, Durrani N, de Poerck D, Rowland MW, Ann Trop Med Parasitol 2001 95 41 46 10.1080/00034980020035906 11235552 (Pubitemid 32178731)
5. Epidemiology of cerebral malaria and its mortality. Durrani AB, Durrani IU, Abbas N, Jabeen M, J Pak Med Assoc 1997 47 213 215 9339620 (Pubitemid 128775826)
6. WHO, World malaria report 2011 Geneva: World Health Organization 2011
7. Resistance of falciparum malaria to chloroquine and sulfadoxine- pyrimethamine in Afghan refugee settlements in western Pakistan: surveys by the general health services using a simplified in vivo test. Rowland M, Durrani N, Hewitt S, Sondorp E, Trop Med Int Health 1997 2 1049 1056 10.1046/j.1365-3156. 1997.d01-185.x 9391507 (Pubitemid 27505238)
8. Clinical trial of extended-dose chloroquine for treatment of resistant falciparum malaria among Afghan refugees in Pakistan. Howard N, Durrani N, Sanda S, Beshir K, Hallett R, Rowland M, Malar J 2011 10 171 10.1186/1475-2875-10-171 21699697
9. WHO, World malaria report 2008 Geneva: World Health Organization 2008
10. WHO, Division of communicable disease control newsletter Geneva: World Health Organization 2005
11. Mutations in the P. falciparum digestive vacuole transmembrane protein Pfcrt and evidence for their role in chloroquine resistance. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
12. Chloroquine-resistant malaria. Wellems TE, Plowe CV, J Infect Dis 2001 184 770 776 10.1086/322858 11517439 (Pubitemid 32826429)
13. A molecular marker for chloroquine-resistant falciparum malaria. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Coulibaly D, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152 (Pubitemid 32108530)
14. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ, Nature 2002 418 320 323 10.1038/nature00813 12124623 (Pubitemid 34790681)
15. Genetic backgrounds of the Plasmodium falciparum chloroquine resistant transporter (pfcrt) alleles in Pakistan. Rawasia WF, Sridaran S, Patel JC, Abdallah J, Ghanchi NK, Barnwell JW, Escalante AA, Udhayakumar V, Beg MA, Infect Genet Evol 2012 12 278 281 10.1016/j.meegid.2011.11.008 22138496
16. Evidence of selective sweeps in genes conferring resistance to chloroquine and pyrimethamine in Plasmodium falciparum isolates in India. Mixson-Hayden T, Jain V, McCollum AM, Poe A, Nagpal AC, Dash AP, Stiles JK, Udhayakumar V, Singh N, Antimicrob Agents Chemother 2010 54 997 1006 10.1128/AAC.00846-09 20038626
17. Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New Guinea. DaRe JT, Mehlotra RK, Michon P, Mueller I, Reeder J, Sharma YD, Stoneking M, Zimmerman PA, Malar J 2007 6 34 10.1186/1475-2875-6-34 17376240 (Pubitemid 46496165)
18. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Cowman AF, Morry MJ, Biggs BA, Cross GA, Foote SJ, Proc Natl Acad Sci USA 1988 85 9109 9113 10.1073/pnas.85.23.9109 3057499 (Pubitemid 19001849)
19. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Peterson DS, Walliker D, Wellems TE, Proc Natl Acad Sci USA 1988 85 9114 9118 10.1073/pnas.85.23.9114 2904149 (Pubitemid 19001850)
20. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Peterson DS, Milhous WK, Wellems TE, Proc Natl Acad Sci U S A 1990 87 3018 3022 10.1073/pnas.87.8.3018 2183222
21. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE, Am J Trop Med Hyg 1995 52 565 568 7611566
22. P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates. Plowe CV, Kublin JG, Doumbo OK, Drug Resist Updat 1998 1 389 396 10.1016/S1368- 7646(98)80014-9 17092820
23. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV, J Infect Dis 2002 185 380 388 10.1086/338566 11807721 (Pubitemid 34107252)
24. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Brooks DR, Wang P, Read M, Watkins WM, Sims PF, Hyde JE, Eur J Biochem 1994 224 397 405 10.1111/j.1432-1033.1994.00397.x 7925353 (Pubitemid 24282821)
25. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Foote SJ, Galatis D, Cowman AF, Proc Natl Acad Sci USA 1990 87 3014 3017 10.1073/pnas.87.8.3014 2183221
26. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Triglia T, Cowman AF, Proc Natl Acad Sci USA 1994 91 7149 7153 10.1073/pnas.91.15.7149 8041761 (Pubitemid 24226820)
27. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Triglia T, Menting JG, Wilson C, Cowman AF, Proc Natl Acad Sci USA 1997 94 13944 13949 10.1073/pnas.94.25. 13944 9391132 (Pubitemid 28009689)
28. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Wang P, Read M, Sims PF, Hyde JE, Mol Microbiol 1997 23 979 986 10.1046/j.1365-2958.1997.2821646.x 9076734 (Pubitemid 27096733)
29. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM, Acta Trop 2005 95 183 193 10.1016/j.actatropica.2005.06.015 16023986 (Pubitemid 41207281)
30. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P, Malar J 2009 8 89 10.1186/1475-2875-8-89 19413906
31. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Staedke SG, Kamya MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED, Rosenthal PJ, Lancet 2001 358 368 374 10.1016/S0140-6736(01)05557-X 11502317 (Pubitemid 32739098)
32. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007. Lim P, Wongsrichanalai C, Chim P, Khim N, Kim S, Chy S, Sem R, Nhem S, Yi P, Duong S, Bouth DM, Genton B, Beck HP, Gobert JG, Rogers WO, Coppee JY, Fandeur T, Mercereau-Puijalon O, Ringwald P, Le BJ, Ariey F, Antimicrob Agents Chemother 2010 54 2135 2142 10.1128/AAC.01304-09 20194689
33. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742 (Pubitemid 39036891)
34. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Price RN, Uhlemann AC, van VM, Brockman A, Hutagalung R, Nair S, Nash D, Singhasivanon P, Anderson TJ, Krishna S, White NJ, Nosten F, Clin Infect Dis 2006 42 1570 1577 10.1086/503423 16652314
35. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Alker AP, Lim P, Sem R, Shah NK, Yi P, Bouth DM, Tsuyuoka R, Maguire JD, Fandeur T, Ariey F, Wongsrichanalai C, Meshnick SR, Am J Trop Med Hyg 2007 76 641 647 17426163 (Pubitemid 351627700)
36. Drug-resistant malaria: molecular mechanisms and implications for public health. Petersen I, Eastman R, Lanzer M, FEBS Lett 2011 585 1551 1562 10.1016/j.febslet.2011.04.042 21530510
37. Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan. Khatoon L, Baliraine FN, Bonizzoni M, Malik SA, Yan G, Am J Trop Med Hyg 2009 81 525 528 19706926
38. High prevalence of double Plasmodium falciparum dhfr mutations at codons 108 and 59 in the Sistan-Baluchistan province, Iran. Zakeri S, Gil JP, Bereckzy S, Djadid ND, Bjorkman A, J Infect Dis 2003 187 1828 1829 10.1086/375250 12751044 (Pubitemid 36667897)
39. Nawaz S, FATA-A Most Dangerous Place Washington, D.C 2009 23984008
40. Departmental audit of malaria control programme 2001-2005 north west frontier province (NWFP). Asif SA, J Ayub Med Coll Abbottabad 2008 20 98 102 19024199
41. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, Mol Biochem Parasitol 1993 58 283 292 10.1016/0166-6851(93)90050-8 8479452
42. Pyrosequencing, a high-throughput method for detecting single nucleotide polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum. Zhou Z, Poe AC, Limor J, Grady KK, Goldman I, McCollum AM, Escalante AA, Barnwell JW, Udhayakumar V, J Clin Microbiol 2006 44 3900 3910 10.1128/JCM.01209-06 16957045 (Pubitemid 44737226)
43. CVD Malaria Group, Protocols [ http://medschool.umaryland.edu/malaria/ protocols.asp ]
44. Selection strength and hitchhiking around two anti-malarial resistance genes. Nash D, Nair S, Mayxay M, Newton PN, Guthmann JP, Nosten F, Anderson TJ, Proc Biol Sci 2005 272 1153 1161 10.1098/rspb.2004.3026 16024377 (Pubitemid 41020275)
45. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. Laufer MK, Takala-Harrison S, Dzinjalamala FK, Stine OC, Taylor TE, Plowe CV, J Infect Dis 2010 202 801 808 10.1086/655659 20662717
46. Differential genetic hitchhiking around mutant pfcrt alleles in the Indian Plasmodium falciparum population. Lumb V, Madan R, Das MK, Rawat V, Dev V, Khan W, Khan H, Sharma YD, J Antimicrob Chemother 2012 67 600 608 10.1093/jac/dkr532 22207595
47. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Ahmed A, Bararia D, Vinayak S, Yameen M, Biswas S, Dev V, Kumar A, Ansari MA, Sharma YD, Antimicrob Agents Chemother 2004 48 879 889 10.1128/AAC.48.3.879-889.2004 14982779 (Pubitemid 38280339)
48. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study. Biswas S, Escalante A, Chaiyaroj S, Angkasekwinai P, Lal AA, Trop Med Int Health 2000 5 737 743 10.1046/j.1365-3156.2000.00632.x 11044269
49. High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine. Zakeri S, Farahani MS, Afsharpad M, Salehi M, Raeisi A, Djadid ND, Int J Infect Dis 2010 14 Suppl 3 123 e128 20399698
50. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine- pyrimethamine in Sri Lanka. Hapuarachchi HC, Dayanath MY, Bandara KB, Abeysundara S, Abeyewickreme W, de Silva NR, Hunt SY, Sibley CH, Am J Trop Med Hyg 2006 74 198 204 16474070 (Pubitemid 46774327)
51. Cost comparison of microscopy vs. empiric treatment for malaria in Southwestern Nigeria: a prospective study. Parikh R, Amole I, Tarpley M, Gbadero D, Davidson M, Vermund SH, Malar J 2010 9 371 10.1186/1475-2875-9-371 21176228
52. Malaria control in Pakistan: new tools at hand but challenging epidemiological realities. Kakar Q, Khan MA, Bile KM, East Mediterr Health J 2010 16 Suppl 54 S60 21495589
53. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India. Saha P, Guha SK, Das S, Mullick S, Ganguly S, Biswas A, Bera DK, Chattopadhyay G, Das M, Kundu PK, Ray K, Maji AK, Antimicrob Agents Chemother 2012 56 2511 2517 10.1128/AAC.05388-11 22314538